Vyloo

Metformin 250mg medicines online

About Metformin 250mg

Metformin 250mg appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
Genericart Metformin Hydrochloride 250mg TabletRx

Genericart Metformin Hydrochloride 250mg Tablet

Swast Aushadhi Seva Generic Medicine Store · 10.0 tablets in 1 strip

₹10
Genericart Metformin Hydrochloride 850mg TabletRx

Genericart Metformin Hydrochloride 850mg Tablet

Swast Aushadhi Seva Generic Medicine Store · 10.0 tablets in 1 strip

₹33
Genericart Metformin+Vildagliptin 850mg/50mg TabletRx

Genericart Metformin+Vildagliptin 850mg/50mg Tablet

Swast Aushadhi Seva Generic Medicine Store · 10.0 tablets in 1 strip

₹238
StayHappi Metformin 850mg TabletRx

StayHappi Metformin 850mg Tablet

Sarvagunaushdhi Pvt Ltd · 10.0 tablets in 1 strip

₹24
Metormin 250mg TabletRx

Metormin 250mg Tablet

Serwina Pharmaceuticals Private Limited · 10.0 tablets in 1 strip

₹16
Met DM 850 XL TabletRx

Met DM 850 XL Tablet

Shrrishti Health Care Products Pvt Ltd · 10.0 tablet xl in 1 strip

₹24
Q Met 250mg TabletRx

Q Met 250mg Tablet

Q Check Speciality Care · 10.0 tablets in 1 strip

₹14
D Met 250mg TabletRx

D Met 250mg Tablet

Strides shasun Ltd · 10.0 tablets in 1 strip

₹8
Vildalip-Met 50/850 TabletRx

Vildalip-Met 50/850 Tablet

Johnlee Pharmaceuticals Pvt Ltd · 15.0 tablets in 1 strip

₹145
Ben Q Met LS 1.25mg/250mg TabletRx

Ben Q Met LS 1.25mg/250mg Tablet

Q Check Speciality Care · 10.0 tablets in 1 strip

₹12
Glimprix-M2 TabletRx

Glimprix-M2 Tablet

Aura Lifecare Private Limited · 10.0 tablets in 1 strip

₹131
Glimin MF 2mg/850mg Tablet SRRx

Glimin MF 2mg/850mg Tablet SR

Divine Savior Pvt Ltd · 10.0 tablet sr in 1 strip

₹62

Frequently asked questions

All salts · Health conditions · Editorial policy